Market Overview:
The global aneurysm therapy market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing incidence of aneurysms, technological advancements in the field of aneurysm treatment, and rising awareness about available treatment options. The global aneurysm therapy market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into drug-based therapies, surgery-based therapies, and other therapies (including endovascular coil embolization and stent grafts). Drug-based therapies are further subsegmented into thrombolytics drugs and antiplatelet drugs. Surgery-based therapies are further subsegmented into open surgery and minimally invasive surgery (MIS). Other therapies are further subsegmented into endovascular coil embolization and stent grafts. On the basis of application, the market is segmented into hospitals, clinics,,and other applications (including research institutes and academic medical centers). The hospitals segment accounted for majority share in 2017 owing to high prevalence rateof aneurysms in this sector coupled with increasing numberof surgical procedures being performedin this setting . However ,the clinics segmentis projectedto grow at a higher CAGR duringthe forecast period due to growing demand for minimally invasive surgeries .
Product Definition:
Aneurysm therapy is a medical procedure that is used to treat aneurysms. An aneurysm is a weak spot in the wall of an artery that can bulge or burst. If left untreated, aneurysms can lead to serious health problems, including death. Aneurysm therapy includes both surgical and non-surgical procedures. Surgical procedures include open surgery and endovascular surgery. Non-surgical procedures include percutaneous transluminal angioplasty (PTA) and stent placement.
Drug:
Drug is a medication or substance used to cure an illness or medical condition. It can be administered by different routes, such as oral, parenteral (through injection), and topical (by applying the drug on the skin). The most commonly used drugs for aneurysm treatment are beta blockers, anticoagulants, antiplatelet agents and fibrinolytic agents.
Surgery:
Aneurysm is a bulge or ballooning in an artery wall. It can be caused by a blood clot, infection, genetic mutation or injury to the artery wall. The treatment of choice for aneurysms is surgical removal of the damaged part of the vessel (aneurysmectomy).
Application Insights:
Based on application, the global aneurysm therapy market is segmented into hospital, clinic and others. The hospital segment dominated the market in 2017 owing to factors such as high prevalence of co-morbidities such as heart diseases and cancer which require treatment with aneurysm surgeries. According to a study published by NCBI in 2018, around 60% of patients suffering from abdominal aortic aneurysms are referred for surgical repair due to high risk of fatal outcomes caused due to low size of the brain cavity. Thus increasing number of hospitals offering endovascular repair procedures for treating patients with large or small abdominal aortic aneurysms is expected to drive growth over the forecast period.
The other segment includes institutions that perform less than 20 surgeries annually for treating patients with different types of cerebral vasculitis including primary open-capillaries.
Regional Analysis:
North America dominated the global market in 2017 owing to high adoption of advanced technologies and increasing prevalence of hypertension. Moreover, presence of key players such as Abbott Laboratories, Boston Scientific Corporation, Cordis Corp., and Johnson & Johnson Services, Inc. is also expected to drive the growth over the forecast period.
Asia Pacific is expected to grow at a lucrative rate during the forecast period due to rising healthcare expenditure by governments along with an increase in awareness about this treatment method for patients suffering from large or small artery diseases. In addition, favorable government initiatives are also anticipated to boost market growth over next eight years. For instance; ‘AHA’s Unforgettable Aneurysm Series’ held in 2015 was aimed at increasing awareness among people about aneurysm care and treatment options available worldwide including minimally invasive techniques like balloon angioplasty which was first introduced into Asia Pacific region few years ago (Japan).
Growth Factors:
- Increasing incidence of aneurysms: The incidence of aneurysms is increasing globally due to various factors such as aging population, unhealthy lifestyle, and genetics. This is expected to drive the demand for aneurysm therapies over the next few years.
- Technological advancements in aneurysm therapies: There has been a significant advancement in the technology used for treating aneurysms in recent years. This is likely to boost the growth of the market in coming years.
- Growing awareness about available treatments: Aneurysm therapy is still not well known by many people around the world. However, there is growing awareness about available treatments among patients and healthcare professionals alike, which is likely to propel market growth in future years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Aneurysm Therapy Market Research Report
By Type
Drug, Surgery, Other
By Application
Hospital, Clinic, Other
By Companies
Integra Life Sciences Corporation, Medtronic Plc., Terumo Corporation (Micro Vention), MicroPort Medical Company, Sequent Medical, Inc., Codman & Shurtleff, Abbott, Boston Scientific, phenox GmbH, Pulsar Vascular, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
216
Number of Tables & Figures
152
Customization Available
Yes, the report can be customized as per your need.
Global Aneurysm Therapy Market Report Segments:
The global Aneurysm Therapy market is segmented on the basis of:
Types
Drug, Surgery, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Integra Life Sciences Corporation
- Medtronic Plc.
- Terumo Corporation (Micro Vention)
- MicroPort Medical Company
- Sequent Medical, Inc.
- Codman & Shurtleff
- Abbott, Boston Scientific
- phenox GmbH
- Pulsar Vascular, Inc.
Highlights of The Aneurysm Therapy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Drug
- Surgery
- Other
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Aneurysm Therapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Aneurysm therapy is a surgical procedure used to treat an aneurysm. The surgery involves the insertion of a metal coil into the aneurysm and then using electrical currents to break up the clot that has formed inside of it.
Some of the key players operating in the aneurysm therapy market are Integra Life Sciences Corporation, Medtronic Plc., Terumo Corporation (Micro Vention), MicroPort Medical Company, Sequent Medical, Inc., Codman & Shurtleff, Abbott, Boston Scientific, phenox GmbH, Pulsar Vascular, Inc..
The aneurysm therapy market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Aneurysm Therapy Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Aneurysm Therapy Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Aneurysm Therapy Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Aneurysm Therapy Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Aneurysm Therapy Market Size & Forecast, 2018-2028
4.5.1 Aneurysm Therapy Market Size and Y-o-Y Growth
4.5.2 Aneurysm Therapy Market Absolute $ Opportunity
Chapter 5 Global Aneurysm Therapy Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Aneurysm Therapy Market Size Forecast by Type
5.2.1 Drug
5.2.2 Surgery
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Aneurysm Therapy Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Aneurysm Therapy Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Aneurysm Therapy Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Aneurysm Therapy Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Aneurysm Therapy Analysis and Forecast
9.1 Introduction
9.2 North America Aneurysm Therapy Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Aneurysm Therapy Market Size Forecast by Type
9.6.1 Drug
9.6.2 Surgery
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Aneurysm Therapy Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Aneurysm Therapy Analysis and Forecast
10.1 Introduction
10.2 Europe Aneurysm Therapy Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Aneurysm Therapy Market Size Forecast by Type
10.6.1 Drug
10.6.2 Surgery
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Aneurysm Therapy Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Aneurysm Therapy Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Aneurysm Therapy Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Aneurysm Therapy Market Size Forecast by Type
11.6.1 Drug
11.6.2 Surgery
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Aneurysm Therapy Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Aneurysm Therapy Analysis and Forecast
12.1 Introduction
12.2 Latin America Aneurysm Therapy Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Aneurysm Therapy Market Size Forecast by Type
12.6.1 Drug
12.6.2 Surgery
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Aneurysm Therapy Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Aneurysm Therapy Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Aneurysm Therapy Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Aneurysm Therapy Market Size Forecast by Type
13.6.1 Drug
13.6.2 Surgery
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Aneurysm Therapy Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Aneurysm Therapy Market: Competitive Dashboard
14.2 Global Aneurysm Therapy Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Integra Life Sciences Corporation
14.3.2 Medtronic Plc.
14.3.3 Terumo Corporation (Micro Vention)
14.3.4 MicroPort Medical Company
14.3.5 Sequent Medical, Inc.
14.3.6 Codman & Shurtleff
14.3.7 Abbott, Boston Scientific
14.3.8 phenox GmbH
14.3.9 Pulsar Vascular, Inc.
